奧基生技股份有限公司
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
Developing genetic testing products related to drug responses and providing pharmacogenomic testing services for precision medicine.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2018
Unified Business No.
50897831
Status
Active
Number of Employees
0
Total Paid-in
Capital
5,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PGx74: A screening platform for drug allergies that develops genetic testing products related to drug responses and provides pharmacogenomic testing services related to precision medicine. The goal is not only to meet the needs of regular health checkup clients for allergy testing of commonly used drugs, but also to satisfy the testing needs of patients regarding drug responses for specific diseases, thereby accelerating the pace of entering the era of personalized medicine.
(The content above was translated by AI.)
(The content above was translated by AI.)
